Trace Wealth Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$364K Hold
6,000
0.27% 48
2025
Q4
$324K Sell
6,000
-585
-9% -$28.1K 0.23% 55
2025
Q3
$297K Sell
6,585
-758
-10% -$35.4K 0.22% 57
2025
Q2
$340K Hold
7,343
0.28% 44
2025
Q1
$448K Buy
7,343
+1
+0% +$58 0.4% 34
2024
Q4
$415K Buy
+7,342
New +$410K 0.37% 36

Other funds holding BMY

Trace Wealth Advisors's BMY Position: Q1 2026 in Review

Trace Wealth Advisors held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 6,000 shares worth $364K. The position accounts for 0.27% of the portfolio, ranked #48.

Trace Wealth Advisors first reported a position in BMY in Q4 2024 and has held it in 6 quarters since. The position peaked at $448K in Q1 2025. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Trace Wealth Advisors held 6,000 shares of Bristol-Myers Squibb worth $364K as of Q1 2026.
  • Trace Wealth Advisors left its Bristol-Myers Squibb share count unchanged in Q1 2026.
  • Bristol-Myers Squibb made up 0.27% of Trace Wealth Advisors's portfolio in Q1 2026, its #48 holding.
  • Trace Wealth Advisors first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 6 quarters since.
  • Trace Wealth Advisors's Bristol-Myers Squibb position peaked at $448K in Q1 2025.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Trace Wealth Advisors's 13F filing for Q1 2026, filed 14 May 2026.